Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (281-290 of 333) with videos related to

Pageof 34
Sort By:
Cancer Research|January 1, 1985
Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndromeE M Hersh, J U Gutterman, S Spector, et al.
Cancer|June 15, 1981
A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemiaM J Keating, T L Smith, K B McCredie, et al.
British Journal of Haematology|July 1, 1991
Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patientsR Kurzrock, M Talpaz, J A Gomez, et al.
Cancer Research|July 15, 1989
Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancerJ L Abbruzzese, B Levin, J A Ajani, et al.
Cancer Research|May 1, 1979
Prognostic factors in metastatic breast cancer treated with combination chemotherapyK D Swenerton, S S Legha, T Smith, et al.
Transplantation Proceedings|September 1, 1973
Host defense, chemical immunosuppression, and the transplant recipient. Relative effects of intermittent versus continuous immunosuppressive therapy with reference to the objectives of treatmentE M Hersh, J U Gutterman, G Mavligit, et al.
Cancer|December 1, 1987
Combined antiestrogen and cytotoxic therapy with pseudomonas vaccine immunotherapy for metastatic breast cancer. A prospective, randomized trialG N Hortobagyi, A U Buzdar, D Frye, et al.
The New England Journal of Medicine|December 17, 1987
Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromesS Vadhan-Raj, M Keating, A LeMaistre, et al.
Medicine|May 1, 1978
Randomized trial of protected environment--prophylactic antibiotics in 145 adults with acute leukemiaV Rodriguez, G P Bodey, E J Freireich, et al.
American Journal of Hematology|March 1, 1990
Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, W S Velasquez, J J Butler, et al.
Pageof 34

Showing results (281-290 of 333) with videos related to

Sort By:
Pageof 34
Cancer Research|January 1, 1985
Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndromeE M Hersh, J U Gutterman, S Spector, et al.
Cancer|June 15, 1981
A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemiaM J Keating, T L Smith, K B McCredie, et al.
British Journal of Haematology|July 1, 1991
Differential dose-related haematological effects of GM-CSF in pancytopenia: evidence supporting the advantage of low- over high-dose administration in selected patientsR Kurzrock, M Talpaz, J A Gomez, et al.
Cancer Research|July 15, 1989
Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancerJ L Abbruzzese, B Levin, J A Ajani, et al.
Cancer Research|May 1, 1979
Prognostic factors in metastatic breast cancer treated with combination chemotherapyK D Swenerton, S S Legha, T Smith, et al.
Transplantation Proceedings|September 1, 1973
Host defense, chemical immunosuppression, and the transplant recipient. Relative effects of intermittent versus continuous immunosuppressive therapy with reference to the objectives of treatmentE M Hersh, J U Gutterman, G Mavligit, et al.
Cancer|December 1, 1987
Combined antiestrogen and cytotoxic therapy with pseudomonas vaccine immunotherapy for metastatic breast cancer. A prospective, randomized trialG N Hortobagyi, A U Buzdar, D Frye, et al.
The New England Journal of Medicine|December 17, 1987
Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromesS Vadhan-Raj, M Keating, A LeMaistre, et al.
Medicine|May 1, 1978
Randomized trial of protected environment--prophylactic antibiotics in 145 adults with acute leukemiaV Rodriguez, G P Bodey, E J Freireich, et al.
American Journal of Hematology|March 1, 1990
Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating factorS Vadhan-Raj, W S Velasquez, J J Butler, et al.
Pageof 34